RATIONALE: Multiple protein kinases have been implicated in cardiovascular disease; however, little is known about the role of their counterparts: the protein phosphatases. OBJECTIVE: To test the hypothesis that mitogen-activated protein kinase phosphatase (MKP)-1 is actively involved in atherogenesis. METHODS AND RESULTS: Mice with homozygous deficiency in MKP-1 (MKP-1(-/-)) were bred with apolipoprotein (Apo)E-deficient mice (ApoE(-/-)) and the 3 MKP-1 genotypes (MKP-1(+/+)/ApoE(-/-) ; MKP-1(+/-)/ApoE(-/-) and MKP-1(-/-)/ApoE(-/-)) were maintained on a normal chow diet for 16 weeks. The 3 groups of mice exhibited similar body weight and serum lipid profiles; however, both MKP-1(+/-) and MKP-1(-/-) mice had significantly less aortic root atherosclerotic lesion formation than MKP-1(+/+) mice. Less en face lesion was observed in 8-month-old MKP-1(-/-) mice. The reduction in atherosclerosis was accompanied by decreased plasma levels of interleukin-1alpha and tumor necrosis factor alpha, and preceded by increased antiinflammatory cytokine interleukin-10. In addition, MKP-1-null mice had higher levels of plasma stromal cell-derived factor-1a, which negatively correlated with atherosclerotic lesion size. Immunohistochemical analysis revealed that MKP-1 expression was enriched in macrophage-rich areas versus smooth muscle cell regions of the atheroma. Furthermore, macrophages isolated from MKP-1-null mice showed dramatic defects in their spreading/migration and impairment in extracellular signal-regulated kinase, but not c-Jun N-terminal kinase and p38, pathway activation. In line with this, MKP-1-null atheroma exhibited less macrophage content. Finally, transplantation of MKP-1-intact bone marrow into MKP-1-null mice fully rescued the wild-type atherosclerotic phenotype. CONCLUSION: These findings demonstrate that chronic deficiency of MKP-1 leads to decreased atherosclerosis via mechanisms involving impaired macrophage migration and defective extracellular signal-regulated kinase signaling.
RATIONALE: Multiple protein kinases have been implicated in cardiovascular disease; however, little is known about the role of their counterparts: the protein phosphatases. OBJECTIVE: To test the hypothesis that mitogen-activated protein kinase phosphatase (MKP)-1 is actively involved in atherogenesis. METHODS AND RESULTS:Mice with homozygous deficiency in MKP-1 (MKP-1(-/-)) were bred with apolipoprotein (Apo)E-deficientmice (ApoE(-/-)) and the 3 MKP-1 genotypes (MKP-1(+/+)/ApoE(-/-) ; MKP-1(+/-)/ApoE(-/-) and MKP-1(-/-)/ApoE(-/-)) were maintained on a normal chow diet for 16 weeks. The 3 groups of mice exhibited similar body weight and serum lipid profiles; however, both MKP-1(+/-) and MKP-1(-/-) mice had significantly less aortic root atherosclerotic lesion formation than MKP-1(+/+) mice. Less en face lesion was observed in 8-month-old MKP-1(-/-) mice. The reduction in atherosclerosis was accompanied by decreased plasma levels of interleukin-1alpha and tumor necrosis factor alpha, and preceded by increased antiinflammatory cytokine interleukin-10. In addition, MKP-1-null mice had higher levels of plasma stromal cell-derived factor-1a, which negatively correlated with atherosclerotic lesion size. Immunohistochemical analysis revealed that MKP-1 expression was enriched in macrophage-rich areas versus smooth muscle cell regions of the atheroma. Furthermore, macrophages isolated from MKP-1-null mice showed dramatic defects in their spreading/migration and impairment in extracellular signal-regulated kinase, but not c-Jun N-terminal kinase and p38, pathway activation. In line with this, MKP-1-null atheroma exhibited less macrophage content. Finally, transplantation of MKP-1-intact bone marrow into MKP-1-null mice fully rescued the wild-type atherosclerotic phenotype. CONCLUSION: These findings demonstrate that chronic deficiency of MKP-1 leads to decreased atherosclerosis via mechanisms involving impaired macrophage migration and defective extracellular signal-regulated kinase signaling.
Authors: S Reddy; S Hama; V Grijalva; K Hassan; R Mottahedeh; G Hough; D J Wadleigh; M Navab; A M Fogelman Journal: J Biol Chem Date: 2001-03-05 Impact factor: 5.157
Authors: Jan K Damås; Torgun Waehre; Arne Yndestad; Thor Ueland; Fredrik Müller; Hans Geir Eiken; Are M Holm; Bente Halvorsen; Stig S Frøland; Lars Gullestad; Pål Aukrust Journal: Circulation Date: 2002-07-02 Impact factor: 29.690
Authors: Andres Alonso; Joanna Sasin; Nunzio Bottini; Ilan Friedberg; Iddo Friedberg; Andrei Osterman; Adam Godzik; Tony Hunter; Jack Dixon; Tomas Mustelin Journal: Cell Date: 2004-06-11 Impact factor: 41.582
Authors: Vladimir R Babaev; Michele Yeung; Ebru Erbay; Lei Ding; Youmin Zhang; James M May; Sergio Fazio; Gökhan S Hotamisligil; MacRae F Linton Journal: Arterioscler Thromb Vasc Biol Date: 2016-04-21 Impact factor: 8.311
Authors: Unni M Chandrasekharan; Matthew Waitkus; Corttrell M Kinney; Alicia Walters-Stewart; Paul E DiCorleto Journal: Arterioscler Thromb Vasc Biol Date: 2010-07-29 Impact factor: 8.311
Authors: Hong Seok Kim; Sarah L Ullevig; Debora Zamora; Chi Fung Lee; Reto Asmis Journal: Proc Natl Acad Sci U S A Date: 2012-09-18 Impact factor: 11.205
Authors: Joel D Boerckel; Unnikrishnan M Chandrasekharan; Matthew S Waitkus; Emily G Tillmaand; Rebecca Bartlett; Paul E Dicorleto Journal: Arterioscler Thromb Vasc Biol Date: 2014-02-27 Impact factor: 8.311
Authors: Michal S Hoffmann; Prachi Singh; Robert Wolk; Krzysztof Narkiewicz; Virend K Somers Journal: Atherosclerosis Date: 2013-10-11 Impact factor: 5.162